Antiinflammation agents

Details for Australian Patent Application No. 2002239806 (hide)

Owner Amgen Inc.

Inventors Labadie, Sharada S.; Cushing, Timothy D.; Jaen, Juan C.; Walker, Nigel P. C.; Hao, Xiaolin; Talamas, Francisco X.; He, Xiao; Browner, Michelle F.; Smith, Marie-Louise; Clark, David L; Hawley, Ronald C

Agent Spruson & Ferguson

Pub. Number AU-B-2002239806

PCT Pub. Number WO02/41843

Priority 60/243,581 26.10.00 US

Filing date 23 October 2001

Wipo publication date 3 June 2002

Acceptance publication date 18 January 2007

International Classifications

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/4745 (2006.01)

A61K 31/5377 (2006.01)

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C12N 15/25 (2006.01) Mutation or genetic engineering

C12N 15/28 (2006.01) Mutation or genetic engineering

Event Publications

12 October 2006 Assignment before Grant

  F. Hoffman-la Roche AG; Tularik Inc. The application has been assigned to Amgen Inc.

18 January 2007 Application Accepted

  Published as AU-B-2002239806

24 May 2007 Standard Patent Sealed

20 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002239807

2002239805